These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16286361)

  • 1. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method.
    Bradford PA; Petersen PJ; Young M; Jones CH; Tischler M; O'Connell J
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3903-9. PubMed ID: 16127069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY; Ng LS; Chen DM
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.
    Hope R; Parsons T; Mushtaq S; James D; Livermore DM
    J Antimicrob Chemother; 2007 Oct; 60(4):770-4. PubMed ID: 17704517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC.
    Torrico M; González N; Giménez MJ; Alou L; Sevillano D; Navarro D; Díaz-Antolín MP; Larrosa N; Aguilar L; Garcia-Escribano N
    J Clin Microbiol; 2010 Jun; 48(6):2243-6. PubMed ID: 20351208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.
    Fernández-Mazarrasa C; Mazarrasa O; Calvo J; del Arco A; Martínez-Martínez L
    J Clin Microbiol; 2009 Mar; 47(3):827-9. PubMed ID: 19144806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stability of MIC values from tetracyclines in different media (author's transl)].
    Schäfer V; Knothe H
    Immun Infekt; 1978 Dec; 6(6):214-6. PubMed ID: 730215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and reproducibility assessment of tigecycline MIC determinations by Etest.
    Bolmström A; Karlsson A; Engelhardt A; Ho P; Petersen PJ; Bradford PA; Jones CH
    J Clin Microbiol; 2007 Aug; 45(8):2474-9. PubMed ID: 17522277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates.
    Petersen PJ; Bradford PA
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3910-8. PubMed ID: 16127070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline: a review of properties, applications, and analytical methods.
    da Silva LM; Nunes Salgado HR
    Ther Drug Monit; 2010 Jun; 32(3):282-8. PubMed ID: 20431506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth.
    Petersen PJ; Jones CH; Bradford PA
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):347-9. PubMed ID: 17662552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
    Dabernat H; Delmas C; Bauriaud R; Lareng MB
    Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S; Tribuddharat C; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
    Fluit AC; Florijn A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
    Tenorio-Abreu A; Eiros JM; Rodríguez-Molins E; Andaluz D; Bobillo F; Domínguez-Gil M; Ortiz de Lejarazu R
    Rev Esp Quimioter; 2010 Jun; 23(2):76-80. PubMed ID: 20559605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY; Potoski BA; Rea R; Adams J; Sethi J; Capitano B; Husain S; Kwak EJ; Bhat SV; Paterson DL
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.